BSX vs VCTR · P/E 20, rev $16.75B vs P/E 14, rev $893.5M
Boston Scientific Corp (BSX) versus Victory Capital Holdings Inc (VCTR) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Victory Capital Holdings Inc (VCTR) is a asset management company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported VCTR revenue for 2024-12-31 was $893.5M. Net income was $288.9M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
Not investment advice. Open the BSX and VCTR stock pages for the full models.
Not investment advice.